Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179568 · ClinicalTrials.gov registry record · Phase 2
A Study of Medication With or Without Psychotherapy for Complicated Grief
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 395
- Enrollment target
NCT01179568 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 395 participants.
The verdict
NCT01179568, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 395 participants
- Enrollment target
Study Summary
The major goal of this 4-site, double blind, placebo-controlled intervention trial is to assess the efficacy of medication (Citalopram) alone or with psychotherapy (Complicated Grief Therapy) to treat the symptoms of complicated grief.
Interventions
- OTHER Placebo
- DRUG Citalopram
- BEHAVIORAL Complicated Grief Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179568
The ClinicalTrials.gov registry entry for NCT01179568 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 395 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01179568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179568 about?
NCT01179568 is a clinical study titled "A Study of Medication With or Without Psychotherapy for Complicated Grief". The major goal of this 4-site, double blind, placebo-controlled intervention trial is to assess the efficacy of medication (Citalopram) alone or with psychotherapy (Complicated Grief Therapy) to treat the symptoms of complicated grief.
What is the current status of trial NCT01179568?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 395 participants. The study started on 2010-03. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01179568?
The interventions under investigation include: Placebo (OTHER), Citalopram (DRUG), Complicated Grief Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01179568?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.